Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01925001
Recruitment Status : Withdrawn (Sangart ceased operations)
First Posted : August 19, 2013
Last Update Posted : October 28, 2013
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : June 2015
  Estimated Study Completion Date : October 2015